Close this search box.
Trending now:  
Valvular and perivalvular thrombus after TAVR: Risks and Outcomes
Dynamic Coronary Roadmap Reduces Contrast Use in Percutaneous Coronary Interventions
Role of Left Ventricular Ejection Fraction in Modern High-Risk PCI with pLVAD Support
TAVI Matches SAVR in Lower Risk Aortic Valve Patients: 10 year outcomes
Lifelong risk of stroke after TAVR: Findings from SwissTAVI Registry

Content for healthcare professionals only

Podcast |

Inflammation as predictor of future cardiovascular event risk

11 Apr 2023
OCT IVUS angiography
Cardiology Update
Cardiology Update
Inflammation as predictor of future cardiovascular event risk

Both inflammation and hyperlipidemia contribute to cardiovascular disease. However in patients receiving statin therapy the relative contributions of inflammation and hyperlipidemia to future CV risk can change. As a result, this has implications on adjunctive therapy choice.

In this episode, Dr. Chadi Alraies discusses a recent study that evaluated high sensitivity CRP and LDL-C as predictors of cardiovascular event risk in patients on statin therapy.

For more cardiology research news join our newsletter or follow us on TwitterFacebookLinkedIn or Instagram

Original article: Ridker PM et al. Lancet. 2023 Mar 3;S0140-6736(23)00215-5.


Related Topics